AMF Tjanstepension AB Sells 249,990 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

AMF Tjanstepension AB lessened its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 47.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 281,733 shares of the pharmacy operator’s stock after selling 249,990 shares during the quarter. AMF Tjanstepension AB’s holdings in Walgreens Boots Alliance were worth $2,639,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. PNC Financial Services Group Inc. lifted its holdings in shares of Walgreens Boots Alliance by 106.6% in the 4th quarter. PNC Financial Services Group Inc. now owns 703,344 shares of the pharmacy operator’s stock worth $6,562,000 after acquiring an additional 362,913 shares during the last quarter. Banco Santander S.A. bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth about $136,000. Candriam S.C.A. lifted its holdings in Walgreens Boots Alliance by 7.1% during the 4th quarter. Candriam S.C.A. now owns 109,734 shares of the pharmacy operator’s stock valued at $1,024,000 after buying an additional 7,247 shares in the last quarter. Lindbrook Capital LLC lifted its holdings in Walgreens Boots Alliance by 126.8% during the 4th quarter. Lindbrook Capital LLC now owns 4,978 shares of the pharmacy operator’s stock valued at $46,000 after buying an additional 2,783 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new stake in Walgreens Boots Alliance during the 4th quarter valued at about $9,685,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Up 7.5 %

NASDAQ WBA opened at $11.39 on Friday. The company’s 50-day simple moving average is $10.64 and its two-hundred day simple moving average is $9.72. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $22.05. The company has a market capitalization of $9.84 billion, a price-to-earnings ratio of -1.11, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. During the same quarter in the previous year, the firm earned $0.66 EPS. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. Equities analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on WBA shares. Truist Financial decreased their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. Bank of America lifted their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and decreased their price objective for the company from $11.00 to $9.00 in a report on Friday, February 28th. Finally, Royal Bank of Canada lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, Walgreens Boots Alliance has a consensus rating of “Hold” and an average target price of $11.54.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.